Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use

Drug and Alcohol Dependence

Volumn 142, Issue , 2014, Pages 301-306

  Dougherty, Donald M ^a   Hill Kapturczak, Nathalie ^a   Liang, Yuanyuan ^a   Karns, Tara E ^a   Cates, Sharon E ^a   Lake, Sarah L ^a   Mullen, Jillian ^a   Roache, John D ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Contingency management; Excessive alcohol use; Transdermal alcohol monitoring

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ALCOHOLISM; ARTICLE; BEHAVIOR CHANGE; CONTINGENCY MANAGEMENT; CONTINUOUS TRANSDERMAL ALCOHOL MONITORING; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REWARD; SELF REPORT; BEHAVIOR THERAPY; PHYSIOLOGIC MONITORING; PROCEDURES; PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ALCOHOL;

ADULT; ALCOHOLISM; BEHAVIOR THERAPY; ETHANOL; FEMALE; HUMANS; MALE; MONITORING, PHYSIOLOGIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905576261     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.06.039     Document Type: Article

References (41)

1. Alessi S.M., Petry N.M. A randomized study of cellphone technology to reinforce alcohol abstinence in the natural environment. Addiction 2013, 108:900-909.
2. Alessi S.M., Hanson T., Wieners M., Petry N.M. Low-cost contingency management in community clinics: delivering incentives partially in group therapy. Exp. Clin. Psychopharmacol. 2007, 15:293-300.
3. Barnett N.P., Tidey J., Murphy J.G., Swift R., Colby S.M. Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor. Drug Alcohol Depend. 2011, 118:391-399.
4. Budney A.J., Higgins S.T., Radonovich K.J., Novy P.L. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J. Consult. Clin. Psychol. 2000, 68:1051-1061.
5. Dougherty D.M., Charles N.E., Acheson A., John S., Furr R.M., Hill-Kapturczak N. Comparing the detection of transdermal and breath alcohol concentrations during periods of alcohol consumption ranging from moderate drinking to binge drinking. Exp. Clin. Psychopharmacol. 2012, 20:373-381.
6. Dougherty D.M., Hill-Kapturczak N., Walters C.J., Cates S.E., Karns T., Roache J.D. Predicting standard alcohol units consumed using transdermal alcohol concentration readings. Addict. Disord. Treat. 2014, (in press).
7. First M.B., Spitzer R.L., Givvon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). Biometrics Research 2001, New York State Psychiatric Institute, New York.
8. Griffith J.D., Rowan-Szal G.A., Roark R.R., Simpson D.D. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000, 58:55-66.
9. Hagedorn H.J., Noorbaloochi S., Simon A.B., Bangerter A., Stitzer M.L., Stetler C.B., Kivlahan D. Rewarding early abstinence in Veterans Health Administration addiction clinics. J. Subst. Abuse Treat. 2013, 45:109-117.
10. Hahn J.A., Woolf-King S.E., Muyindike W. Adding fuel to the fire: alcohol's effect on the HIV epidemic in Sub-Saharan Africa. Curr. HIV/AIDS Rep. 2011, 8:172-180.
11. Hedayat A.S., Stufken J. Optimal and efficient crossover designs under different assumptions about the carryover effects. J. Biopharm. Stat. 2003, 13:519-528.
12. Helander A., Peter O., Zheng Y. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. Alcohol Alcohol. 2012, 47:552-557.
13. Helander A., Jaeken J., Matthijs G., Eggertsen G. Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption. Clin. Chim. Acta 2014, 431:15-18.
14. Higgins S.T., Silverman K. Contingency Management 2008, American Psychiatric Publishing, Arlington, VA.
15. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Ogden D., Badger G.J. Outpatient behavioral treatment for cocaine dependence: one-year outcome. Exp. Clin. Psychopharmacol. 1995, 3:205-212.
16. Higgins S.T., Wong C.J., Badger G.J., Ogden D.E.H., Dantona R.L. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J. Consult. Clin. Psychol. 2000, 68:64-72.
17. Higgins S.T., Heil S.H., Dantona R., Donham R., Matthews M., Badger G.J. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction 2006, 102:271-281.
18. Hill-Kapturczak N., Roache J.D., Liang Y.Y., Karns T.E., Cates S.E., Dougherty D.M. Accounting for sex-related differences in the estimation of breath alcohol levels using transdermal alcohol monitoring. Psychopharmacology 2014, (in press). 10.1007/s00213-014-3644-9.
19. Hunt G.M., Azrin N.H. A community-reinforcement approach to alcoholism. Behav. Res. Ther. 1973, 11:91-104.
20. Koffarnus M.N., Wong C.J., Diemer K., Needham M., Hampton J., Fingerhood M., Svikis D.S., Bigelow G.E., Silverman K. A randomized clinical trial of a therapeutic workplace for chronically unemployed, homeless, alcohol-dependent adults. Alcohol Alcohol. 2011, 46:561-569.
21. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
22. Maenhout T.M., De Buyzere M.L., Delanghe J.R. Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin. Chim. Acta 2013, 415:322-329.
23. Marques P.R. Levels and types of alcohol biomarkers in DUI and clinic samples for estimating workplace alcohol problems. Drug Test. Anal. 2012, 4:76-82.
24. Marques P., Tippetts S., Allen J., Javors M., Alling C., Yegles M., Pragst F., Wurst F. Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives. Addiction 2010, 105:226-239.
25. McDonell M.G., Srebnik D., Angelo F., Sugar A.M., Howell D., Rainey C., Roll J., Short R., Reis R. Evaluation of ethyl glucuronide immunoassay urinalysis in five alcohol-dependent outpatients. Am. J. Addict. 2011, 20:482-484.
26. McDonell M.G., Howell H., McPherson S., Cameron J.M., Srebnik D., Roll J.M., Ries R.K. Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker. J. Appl. Behav. Anal. 2012, 45:161-165.
27. Miller P.M. A behavioral intervention program for chronic public drunkenness offenders. Arch. Gen. Psychiatry 1975, 32:915-918.
28. Miller P.M., Hersen M., Eisler R.M. Relative effectiveness of instructions, agreements, and reinforcement in behavioral contracts with alcoholics. J. Abnorm. Psychol. 1974, 83:548-553.
29. Miller P.M., Hersen M., Eisler R.M., Watts J.G. Contingent reinforcement of lowered blood/alcohol levels in an outpatient chronic alcoholic. Behav. Res. Ther. 1974, 12:261-263.
30. Rethinking Drinking. NIH Publication No. 13-3770 2010, National Institute on Alcohol Abuse and Alcoholism (NIAAA), U.S. Department of Health and Human Services, Washington, DC.
31. Petry N.M., Martin B., Cooney J.L., Kranzler H.R. Give them prizes and they will come: contingency management for treatment of alcohol dependence. J. Consult. Clin. Psychol. 2000, 68:250-257.
32. Petry N.M., Alessi S.M., Marx J., Austin M., Tardif M. Vouchers versus prizes: contingency management treatment of substance abusers in community settings. J. Consult. Clin. Psychol. 2005, 73:1005-1014.
33. Petry N.M., Martin B., Simcic F. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J. Consult. Clin. Psychol. 2005, 73:354-359.
34. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006, 101:1546-1560.
35. Roll J.M., Chudzynski J., Cameron J.M., Howell D.N., McPherson S. Duration effects in contingency management treatment of methamphetamine disorders. Addict. Behav. 2013, 38:2455-2462.
36. Rosenberg H., Davis M.A. Differences in the acceptability of non-abstinence goals by type of drug among American substance abuse clinicians. J. Subst. Abuse Treat. 2014, 46:214-218.
37. Sobell L.C., Sobell M.B. Timeline follow-back: a technique for assessing self-reported ethanol consumption. Measure Alcohol Consumption: Psychosocial and Biological Methods 1992, 41-72. Humana Press, Totowa, NJ. J. Allen, R.X. Litten (Eds.).
38. Stitzer M., Petry N. Contingency management for treatment of substance abuse. Annu. Rev. Clin. Psychol. 2006, 2:411-434.
39. Swift R. Transdermal alcohol measurement for estimation of blood alcohol concentration. Alcohol.: Clin. Exp. Res. 2000, 24:422-423.
40. Swift R. Direct measurement of alcohol and its metabolites. Addiction 2003, 98:73-80.
41. Wechsler D. Wechsler Abbreviated Scale of Intelligence 1999, The Psychological Corporation, Harcourt Brace and Company, New York, NY.